Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Oncoceutics licenses rights for its anti-cancer compound to Ohara

biospectrumasiaMarch 12, 2019

Tag: Oncoceutics , licenses rights , anti-cancer compound

PharmaSources Customer Service